Diarylhydantoin compounds
View Patent ↗The present invention relates to diarylhydantoin compounds, including diarylthiohydantoins, and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer.
1. A compound selected from the group consisting of
2. The compound of claim 1 having the formula
3. The compound of claim 1 , having the formula
4. The compound of claim 1 , having the formula
5. A pharmaceutical composition comprising a therapeutically effective amount of a compound according to claim 2 , or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or diluent.
6. A pharmaceutical composition comprising a therapeutically effective amount of a compound according to claim 3 , or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or diluent.
7. A pharmaceutical composition comprising a therapeutically effective amount of a compound according to claim 4 , or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or diluent.
8. A pharmaceutical acceptable salt of a compound according to claim 1 .
9. A pharmaceutical composition comprising a therapeutically effective amount of a compound according to claim 1 , or a pharmaceutically acceptable salt of a compound of claim 1 , and a pharmaceutically acceptable carrier or diluent.
10. A pharmaceutical composition according to claim 9 , wherein the compound is dissolved.
11. A pharmaceutical composition according to claim 9 , comprising a solvent.
12. A pharmaceutical composition according to claim 9 comprising one or more of dimethylsulfoxide (DSMO), polyethylene glycol (PEG), and water.
13. A pharmaceutical composition according to claim 9 , dimethylsulfoxide (DSMO), polyethylene glycol (PEG), and water.